Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
51.31B
Market cap51.31B
Price-Earnings ratio
20.32
Price-Earnings ratio20.32
Dividend yield
0.89%
Dividend yield0.89%
Average volume
1.77M
Average volume1.77M
High today
$266.26
High today$266.26
Low today
$261.35
Low today$261.35
Open price
$265.67
Open price$265.67
Volume
1.52M
Volume1.52M
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

The current Cencora, Inc.(COR) stock price is $263.64, with a market capitalization of 51.31B. The stock trades at a price-to-earnings (P/E) ratio of 20.32 and offers a dividend yield of 88.7%.

On 2026-06-03, Cencora, Inc.(COR) stock moved within a range of $261.35 to $266.26. With shares now at $263.64, the stock is trading +0.9% above its intraday low and -1.0% below the session's peak.

Trading activity shows a volume of 1.52M, compared to an average daily volume of 1.77M.

The stock's 52-week range extends from a low of $244.82 to a high of $377.54.

The stock's 52-week range extends from a low of $244.82 to a high of $377.54.

COR News

MarketWatch 2d
Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch

...

Cencora Inc. stock outperforms competitors despite losses on the day - MarketWatch
Simply Wall St 3d
Insider Spends US$1.1m Buying More Shares In Cencora

Those following along with Cencora, Inc. ( ) will no doubt be intrigued by the recent purchase of shares by Mark M. Durcan, Independent Chairman of the Board of...

Insider Spends US$1.1m Buying More Shares In Cencora
Simply Wall St 4d
Assessing Cencora Valuation After Recent Share Price Weakness And Long Term Gains

Advertisement Recent share performance snapshot Cencora (COR) has seen its stock decline about 13% over the past month and roughly 28% over the past 3 months,...

Assessing Cencora Valuation After Recent Share Price Weakness And Long Term Gains

Analyst ratings

83%

of 18 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

More COR News

TipRanks 5d
Cencora Names New CFO and Reaffirms 2026 Outlook

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

TipRanks 6d
Cencora Insider Makes Bold Multi-Million-Dollar Move in Fresh Stock Buy

New insider activity at Cencora ( (COR) ) has taken place on May 28, 2026. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst rati...

Simply Wall St 7d
Is Cencora Starting To Look Attractive After Recent Healthcare Distribution Headlines?

If you are wondering whether Cencora at about US$270.78 is starting to look attractive or stretched, the key question is what you are really paying for its futu...

Is Cencora Starting To Look Attractive After Recent Healthcare Distribution Headlines?

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.